Cargando…
No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer’s Disease: A Randomised Controlled Trial
Findings from epidemiological and observational studies have indicated that diets high in omega-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) may reduce the risk of cognitive decline and Alzheimer’s disease (AD). To determine if increasing i...
Autores principales: | Phillips, Michelle A., Childs, Caroline E., Calder, Philip C., Rogers, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632767/ https://www.ncbi.nlm.nih.gov/pubmed/26501267 http://dx.doi.org/10.3390/ijms161024600 |
Ejemplares similares
-
Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer’s disease
por: Wood, Amy H. R., et al.
Publicado: (2021) -
Omega-3 Polyunsaturated Fatty Acids and the Intestinal Epithelium—A Review
por: Durkin, Luke A., et al.
Publicado: (2021) -
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
por: Knöchel, Christian, et al.
Publicado: (2015) -
Omega-3 fatty acids related to cognitive impairment in patients with schizophrenia
por: Satogami, Kazumi, et al.
Publicado: (2017) -
Omega-3 fatty acid supplementation and cognitive function: are smaller dosages more beneficial?
por: Abubakari, Abdul-Razak, et al.
Publicado: (2014)